Bladder urothelial carcinoma cell lines sensitive to TRAIL-induced apoptosis were found to have increased death receptor expression, while TRAIL-resistant cancer lines had decreased DR5 receptor expression [30]. The gene discussed is TNFSF10; the disease is bladder transitional cell carcinoma.